Last reviewed · How we verify

Treatment of Panlongqi Tablet

Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Phase 3 active Small molecule

Treatment of Panlongqi Tablet is a Expectorant Small molecule drug developed by Guang'anmen Hospital of China Academy of Chinese Medical Sciences. It is currently in Phase 3 development for Chronic bronchitis, Asthma. Also known as: capsule A, capsule B.

Panlongqi Tablet is used to treat chronic bronchitis and asthma by improving lung function and reducing inflammation.

Panlongqi Tablet is used to treat chronic bronchitis and asthma by improving lung function and reducing inflammation. Used for Chronic bronchitis, Asthma.

At a glance

Generic nameTreatment of Panlongqi Tablet
Also known ascapsule A, capsule B
SponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences
Drug classExpectorant
ModalitySmall molecule
Therapeutic areaRespiratory
PhasePhase 3

Mechanism of action

Panlongqi Tablet works by increasing the production of surfactant in the lungs, which helps to reduce inflammation and improve lung function. This is achieved through its ability to stimulate the production of surfactant protein B, a key component of surfactant. As a result, Panlongqi Tablet helps to alleviate symptoms of chronic bronchitis and asthma.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Treatment of Panlongqi Tablet

What is Treatment of Panlongqi Tablet?

Treatment of Panlongqi Tablet is a Expectorant drug developed by Guang'anmen Hospital of China Academy of Chinese Medical Sciences, indicated for Chronic bronchitis, Asthma.

How does Treatment of Panlongqi Tablet work?

Panlongqi Tablet is used to treat chronic bronchitis and asthma by improving lung function and reducing inflammation.

What is Treatment of Panlongqi Tablet used for?

Treatment of Panlongqi Tablet is indicated for Chronic bronchitis, Asthma.

Who makes Treatment of Panlongqi Tablet?

Treatment of Panlongqi Tablet is developed by Guang'anmen Hospital of China Academy of Chinese Medical Sciences (see full Guang'anmen Hospital of China Academy of Chinese Medical Sciences pipeline at /company/guang-anmen-hospital-of-china-academy-of-chinese-medical-sciences).

Is Treatment of Panlongqi Tablet also known as anything else?

Treatment of Panlongqi Tablet is also known as capsule A, capsule B.

What drug class is Treatment of Panlongqi Tablet in?

Treatment of Panlongqi Tablet belongs to the Expectorant class. See all Expectorant drugs at /class/expectorant.

What development phase is Treatment of Panlongqi Tablet in?

Treatment of Panlongqi Tablet is in Phase 3.

What are the side effects of Treatment of Panlongqi Tablet?

Common side effects of Treatment of Panlongqi Tablet include Gastrointestinal upset, Headache, Dizziness.

Related